New Delhi, Oct 08: The Drugs Controller General of India emphasised the “critical importance of testing new materials, including the excipients, before their use in the manufacturing of pharmaceutical formulations.

The DCGI orders came in the wake of Madhya Pradesh’s cough syrup deaths, stating that there have been recent reports of child deaths in Chhindwara, Madhya Pradesh, allegedly linked to contaminated cough syrups and concerns related to the quality of these cough syrups.

The directive follows inspections revealing lapses in compliance, where some manufacturers were reportedly failing to conduct adequate testing of raw materials and inactive ingredients before production.

During the inspections carried out at the manufacturing facilities and in the investigations of the drug decl

See Full Page